Legal & General Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35B Sell
19,538,545
-238,297
-1% -$27.5M 0.54% 25
2025
Q4
$2.08B Sell
19,776,842
-882,315
-4% -$82.8M 0.46% 29
2025
Q3
$1.73B Buy
20,659,157
+1,156,112
+6% +$95.2M 0.39% 33
2025
Q2
$1.54B Sell
19,503,045
-252,263
-1% -$20.1M 0.38% 34
2025
Q1
$1.77B Buy
19,755,308
+270,797
+1% +$25.3M 0.48% 27
2024
Q4
$1.94B Buy
19,484,511
+241,709
+1% +$24.9M 0.51% 26
2024
Q3
$2.19B Buy
19,242,802
+555,695
+3% +$66M 0.57% 22
2024
Q2
$2.31B Sell
18,687,107
-555,928
-3% -$71.6M 0.65% 20
2024
Q1
$2.54B Sell
19,243,035
-144,648
-0.7% -$17.8M 0.73% 18
2023
Q4
$2.11B Sell
19,387,683
-752,004
-4% -$78.1M 0.66% 20
2023
Q3
$2.07B Sell
20,139,687
-545,917
-3% -$58.8M 0.72% 19
2023
Q2
$2.39B Buy
20,685,604
+1,097,735
+6% +$125M 0.78% 18
2023
Q1
$2.08B Buy
19,587,869
+398,252
+2% +$43M 0.75% 17
2022
Q4
$2.13B Sell
19,189,617
-514,995
-3% -$52.6M 0.82% 16
2022
Q3
$1.7B Sell
19,704,612
-575,045
-3% -$51.3M 0.66% 22
2022
Q2
$1.85B Sell
20,279,657
-17,399
-0.1% -$1.54M 0.65% 23
2022
Q1
$1.67B Buy
20,297,056
+1,192,643
+6% +$94M 0.51% 28
2021
Q4
$1.46B Sell
19,104,413
-12,213
-0.1% -$973K 0.44% 35
2021
Q3
$1.44B Buy
19,116,626
+832,409
+5% +$63.3M 0.47% 34
2021
Q2
$1.42B Buy
18,284,217
+452,722
+3% +$33.7M 0.48% 30
2021
Q1
$1.31B Sell
17,831,495
-272,792
-2% -$20.1M 0.49% 30
2020
Q4
$1.41B Buy
18,104,287
+261,726
+1% +$20M 0.55% 26
2020
Q3
$1.41B Sell
17,842,561
-232,464
-1% -$18.2M 0.63% 21
2020
Q2
$1.33B Buy
18,075,025
+331,901
+2% +$25M 0.64% 22
2020
Q1
$1.3B Buy
17,743,124
+528,802
+3% +$41.6M 0.76% 18
2019
Q4
$1.49B Buy
17,214,322
+690,630
+4% +$56.7M 0.71% 21
2019
Q3
$1.33B Buy
16,523,692
+28,091
+0.2% +$2.25M 0.7% 23
2019
Q2
$1.32B Sell
16,495,601
-181,977
-1% -$13.9M 0.71% 25
2019
Q1
$1.32B Buy
16,677,578
+2,601,382
+18% +$195M 0.76% 22
2018
Q4
$1.03B Buy
14,076,196
+684,478
+5% +$48.3M 0.8% 22
2018
Q3
$906M Sell
13,391,718
-4,177
-0% -$266K 0.65% 25
2018
Q2
$776M Sell
13,395,895
-731,744
-5% -$41.3M 0.6% 26
2018
Q1
$734M Sell
14,127,639
-891,612
-6% -$48.2M 0.56% 29
2017
Q4
$806M Sell
15,019,251
-344,566
-2% -$19.1M 0.58% 30
2017
Q3
$939M Buy
15,363,817
+100,338
+0.7% +$6.08M 0.71% 24
2017
Q2
$933M Buy
15,263,479
+201,581
+1% +$12.3M 0.75% 21
2017
Q1
$913M Buy
15,061,898
+523,334
+4% +$31.8M 0.77% 19
2016
Q4
$817M Buy
14,538,564
+74,971
+0.5% +$4.39M 0.76% 22
2016
Q3
$861M Buy
14,463,593
+58,838
+0.4% +$3.44M 0.87% 18
2016
Q2
$792M Buy
14,404,755
+124,168
+0.9% +$6.61M 0.83% 18
2016
Q1
$721M Buy
14,280,587
+159,348
+1% +$7.8M 0.8% 21
2015
Q4
$712M Buy
14,121,239
+68,000
+0.5% +$3.43M 0.8% 23
2015
Q3
$662M Buy
14,053,239
+414,590
+3% +$22M 0.81% 20
2015
Q2
$741M Buy
13,638,649
+260,373
+2% +$14.6M 0.87% 17
2015
Q1
$734M Buy
13,378,276
+71,676
+0.5% +$4.06M 0.88% 14
2014
Q4
$721M Sell
13,306,600
-358,792
-3% -$20M 0.85% 16
2014
Q3
$773M Sell
13,665,392
-885,057
-6% -$49.7M 0.93% 16
2014
Q2
$803M Buy
14,550,449
+210,563
+1% +$11.5M 0.94% 14
2014
Q1
$777M Sell
14,339,886
-290,813
-2% -$15.1M 0.94% 16
2013
Q4
$699M Sell
14,630,699
-44,934
-0.3% -$2.05M 0.85% 17
2013
Q3
$667M Sell
14,675,633
-524,732
-3% -$24M 0.88% 17
2013
Q2
$674M Buy
+15,200,365
New +$679M 0.93% 18

Other funds holding MRK

Legal & General Group's MRK Position: Q1 2026 in Review

Legal & General Group reduced its Merck (MRK) stake by 1.2% in Q1 2026, selling an estimated $27.5M and leaving 19,538,545 shares worth $2.35B. The position accounts for 0.54% of the portfolio, ranked #25.

Legal & General Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.54B in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Legal & General Group held 19,538,545 shares of Merck worth $2.35B as of Q1 2026.
  • Legal & General Group sold 238,297 Merck shares in Q1 2026, an estimated $27.5M.
  • Merck made up 0.54% of Legal & General Group's portfolio in Q1 2026, its #25 holding.
  • Legal & General Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Legal & General Group's Merck position peaked at $2.54B in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.